THOMAS M DOOLIN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MIDDLEBURGH, NY NPI 1043347784

General Payments — all program years on this page

$4,101.93

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,707.45 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,707.4518

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $817.688
ABBVIE INC. $269.584
GlaxoSmithKline, LLC. $235.992
Lilly USA, LLC $234.842
Amgen Inc. $123.461
Boehringer Ingelheim Pharmaceuticals, Inc. $25.901

By program year

Program yearAmountRecords
2021 $231.862
2022 $533.805
2023 $1,628.8216
2024 $1,707.4518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104200369 AstraZeneca Pharmaceuticals LP $24.29 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104220443 AstraZeneca Pharmaceuticals LP $113.13 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104276605 AstraZeneca Pharmaceuticals LP $121.84 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104305104 AstraZeneca Pharmaceuticals LP $121.84 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104739289 AstraZeneca Pharmaceuticals LP $124.99 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105203845 AstraZeneca Pharmaceuticals LP $115.20 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105353438 AstraZeneca Pharmaceuticals LP $121.39 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105621717 AstraZeneca Pharmaceuticals LP $75.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107035196 ABBVIE INC. $125.00 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107035198 ABBVIE INC. $9.52 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107035200 ABBVIE INC. $9.09 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107035202 ABBVIE INC. $125.97 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116354154 GlaxoSmithKline, LLC. $122.88 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116464050 GlaxoSmithKline, LLC. $113.11 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117241084 Amgen Inc. $123.46 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117849241 Boehringer Ingelheim Pharmaceuticals, Inc. $25.90 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135964896 Lilly USA, LLC $124.76 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135979688 Lilly USA, LLC $110.08 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.